OBJECTIVES: We aimed to investigate the diagnostic accuracy of a standardized computed tomography angiography (CTA) for the identification of significant coronary artery disease (CAD) in patients evaluated for transcatheter aortic valve implantation (TAVI). BACKGROUND: The diagnostic performance of CTA for the detection of CAD in patients with aortic stenosis referred for TAVI has thus far not been validated. METHODS: A consecutive series of 475 patients (194 male, mean age: 82 ± 6 years) with CTA data sets obtained during the routine diagnostic work-up before TAVI were included. A total of 6,603 coronary segments in 1,899 coronary arteries ≥ 1.5 mm in diameter and 271 grafts were evaluated for the presence of significant CAD defined as ≥ 50% luminal narrowing. Results were compared with invasive coronary angiography as the standard of reference. RESULTS: Prevalence of significant CAD was 57% (270/475), and 5,925 coronary segments (90%) and 257 bypass grafts (95%) were evaluable by CTA. In the per-patient analysis, sensitivity (Se), specificity, and positive and negative predictive values (NPV) were 98, 37, 67 and 94%, respectively. CTA showed satisfactory ability to exclude significant CAD in the following subgroups: (1) patients (221/475) without prior known CAD (Se: 97%, NPV: 97%), (2) patients (13/475) without prior known CAD and absent coronary calcification (NPV: 100%) and (3) bypass grafts (Se: 97%, NPV: 99%). CONCLUSIONS: Comprehensive evaluation of a pre-TAVI CTA could prove to be a useful rule-out test for significant CAD in selected subgroups of patients.
OBJECTIVES: We aimed to investigate the diagnostic accuracy of a standardized computed tomography angiography (CTA) for the identification of significant coronary artery disease (CAD) in patients evaluated for transcatheter aortic valve implantation (TAVI). BACKGROUND: The diagnostic performance of CTA for the detection of CAD in patients with aortic stenosis referred for TAVI has thus far not been validated. METHODS: A consecutive series of 475 patients (194 male, mean age: 82 ± 6 years) with CTA data sets obtained during the routine diagnostic work-up before TAVI were included. A total of 6,603 coronary segments in 1,899 coronary arteries ≥ 1.5 mm in diameter and 271 grafts were evaluated for the presence of significant CAD defined as ≥ 50% luminal narrowing. Results were compared with invasive coronary angiography as the standard of reference. RESULTS: Prevalence of significant CAD was 57% (270/475), and 5,925 coronary segments (90%) and 257 bypass grafts (95%) were evaluable by CTA. In the per-patient analysis, sensitivity (Se), specificity, and positive and negative predictive values (NPV) were 98, 37, 67 and 94%, respectively. CTA showed satisfactory ability to exclude significant CAD in the following subgroups: (1) patients (221/475) without prior known CAD (Se: 97%, NPV: 97%), (2) patients (13/475) without prior known CAD and absent coronary calcification (NPV: 100%) and (3) bypass grafts (Se: 97%, NPV: 99%). CONCLUSIONS: Comprehensive evaluation of a pre-TAVI CTA could prove to be a useful rule-out test for significant CAD in selected subgroups of patients.
Authors: Willem B Meijboom; Nico R Mollet; Carlos A G Van Mieghem; Jolanda Kluin; Annick C Weustink; Francesca Pugliese; Eleni Vourvouri; Filippo Cademartiri; Ad J J C Bogers; Gabriel P Krestin; Pim J de Feyter Journal: J Am Coll Cardiol Date: 2006-09-26 Impact factor: 24.094
Authors: Annick C Weustink; Koen Nieman; Fransesca Pugliese; Nico R Mollet; W Bob Meijboom; Bob W Meijboom; Carlos van Mieghem; Gert-Jan ten Kate; Filippo Cademartiri; Gabriel P Krestin; Pim J de Feyter Journal: JACC Cardiovasc Imaging Date: 2009-07
Authors: Refat Jabara; Nicolas Chronos; Larry Klein; Steven Eisenberg; Rebecca Allen; Shannon Bradford; Stephen Frohwein Journal: Am J Cardiol Date: 2007-04-13 Impact factor: 2.778
Authors: Moritz Seiffert; Jan-Malte Sinning; Alexander Meyer; Sandra Wilde; Lenard Conradi; Mariuca Vasa-Nicotera; Alexander Ghanem; Jörg Kempfert; Christoph Hammerstingl; Francisco M Ojeda; Won-Keun Kim; Dietmar H Koschyk; Johannes Schirmer; Stephan Baldus; Eberhard Grube; Helge Möllmann; Hermann Reichenspurner; Georg Nickenig; Stefan Blankenberg; Patrick Diemert; Hendrik Treede; Thomas Walther; Nikos Werner; Renate B Schnabel Journal: Clin Res Cardiol Date: 2014-03-19 Impact factor: 5.460
Authors: Won-Keun Kim; Alexander Meyer; Helge Möllmann; Andreas Rolf; Susanne Möllmann; Johannes Blumenstein; Arnaud Van Linden; Christian W Hamm; Thomas Walther; Jörg Kempfert Journal: Clin Res Cardiol Date: 2016-02-18 Impact factor: 5.460
Authors: Won-Keun Kim; Johannes Blumenstein; Christoph Liebetrau; Andreas Rolf; Luise Gaede; Arnaud Van Linden; Mani Arsalan; Mirko Doss; Jan G P Tijssen; Christian W Hamm; Thomas Walther; Helge Möllmann Journal: Clin Res Cardiol Date: 2017-08-09 Impact factor: 5.460
Authors: Marco M Ochs; Fabian Aus dem Siepen; Thomas Fritz; Florian Andre; Gitsios Gitsioudis; Grigorios Korosoglou; Sebastian Seitz; Yuriy Bogomazov; Christopher L Schlett; Roman Sokiranski; Andre Sommer; Friedemann Gückel; Matthias Brado; Hans-Ulrich Kauczor; Johannes Görich; Matthias G W Friedrich; Hugo A Katus; Sebastian J Buss Journal: Clin Res Cardiol Date: 2017-02-06 Impact factor: 5.460
Authors: Gianluca Pontone; Alexia Rossi; Marco Guglielmo; Marc R Dweck; Oliver Gaemperli; Koen Nieman; Francesca Pugliese; Pal Maurovich-Horvat; Alessia Gimelli; Bernard Cosyns; Stephan Achenbach Journal: Eur Heart J Cardiovasc Imaging Date: 2022-03-22 Impact factor: 9.130
Authors: Axel Schmermund; Mohamed Marwan; Jörg Hausleiter; Sebastian Barth; Oliver Bruder; Sebastian Kerber; Grigorius Korosoglou; Alexander Leber; Werner Moshage; Stephen Schröder; Steffen Schneider; Jochen Senges; Stephan Achenbach Journal: Clin Res Cardiol Date: 2017-07-19 Impact factor: 5.460
Authors: Hendrik Wienemann; Marcel C Langenbach; Victor Mauri; Maryam Banazadeh; Konstantin Klein; Christopher Hohmann; Samuel Lee; Isabel Breidert; Alexander Hof; Kaveh Eghbalzadeh; Elmar Kuhn; Marcel Halbach; David Maintz; Stephan Baldus; Alexander Bunck; Matti Adam Journal: J Cardiovasc Dev Dis Date: 2022-04-14